Source: Alpha Cognition.
  • Alpha Cognition (ACOG) has withdrawn its marketed public offering
  • Current market conditions were deemed not conducive to an offering on terms that would be in the best interests of the company’s stockholders
  • Alpha Cognition is a clinical-stage biopharmaceutical company developing treatments for underserved neurodegenerative diseases
  • Alpha Cognition Inc. (ACOG) is down 10 per cent on the day, trading at C$0.36 per share at 1:45 pm ET

Alpha Cognition (ACOG) has withdrawn its previously-announced marketed public offering.

The company’s management determined that current market conditions are not conducive to an offering on terms that would be in the best interests of the company’s stockholders.

No securities will be sold pursuant to the offering.

Alpha Cognition is a clinical-stage biopharmaceutical company developing treatments for underserved neurodegenerative diseases.

Alpha Cognition Inc. (ACOG) is down 10 per cent on the day, trading at C$0.36 per share at 1:45 pm ET.

More From The Market Online

KWESST to provide situational awareness for the Canadian Red Cross

KWESST Micro Systems (TSXV:KWE) wins a contract to provide a situational awareness app to support the Canadian Red Cross.

Air Canada stock rises as service from Ottawa grows

Air Canada (TSX:AC) boosts its schedule serving Ottawa by almost 60 per cent with more flights across the nation.

Odd Burger to add 40 locations in Florida

Odd Burger (TSXV:ODD) will develop 40 new locations in Florida over the next eight years, with its sights set on further U.S. expansion.